{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:46:37Z","timestamp":1791845197217,"version":"4.3.4"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To assess photon counting CT (PCCT) spectral parameters in the differentiation of locally recurrent pancreatic adenocarcinoma (PDAC) from benign postsurgical fibrosis after PDAC surgical resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Twenty-two patients [12 male, mean\u00b1SD: age 71 (8) y] who underwent pancreas protocol PCCT following surgery for PDAC were retrospectively identified. Local recurrence required tissue histopathology or enlarging FDG-avid soft tissue. Nonrecurrence required soft-tissue reduction with stable or decreased CA 19-9. Two blinded radiologists independently drew regions of interest within the surgical bed soft tissue to determine iodine density (I), I normalized to aortic enhancement (I%), fat fraction, and extracellular volume (ECV), which were compared using the Mann-Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      test.\n                      <jats:italic toggle=\"yes\">A P<\/jats:italic>\n                      &lt;0.05 indicated statistical significance. The intraclass correlation coefficient was used to assess inter-reader reliability. ROC analysis was performed using mean measurements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      On pancreatic parenchymal phase imaging, median [IQR] postcontrast attenuation for patients with nonrecurrence (n=10) and recurrence (n=11) was 32.3 (16.4 to 42.9\u00a0HU) and 57.0 (50.2 to 65.5\u00a0HU)(\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.001); enhancement was 23.7 (10.2 to 26.0\u00a0HU) and 40.0 (34.4 to 44.5\u00a0HU) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.001); I was 0.6 (0.5 to 0.90\u00a0mg\/mL) and 1.8 (1.5 to 2.0\u00a0mg\/mL) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001); I% was 8.3 (6.3% to 11.1%) and 34.3 (29.8% to 40.9%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001); and ECV was 5.8 (4.4 to 6.9\u00a0mL) and 23.0 (18.0 to 25.8\u00a0mL) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001), respectively. To differentiate nonrecurrent from recurrent soft tissue, a postcontrast 45.7\u00a0HU threshold had 100% sensitivity and 80% specificity [AUC=0.92 (0.80-1.00)]; enhancement of 31.9\u00a0HU had 81.8% sensitivity and 100% specificity [AUC=0.98 (0.93-1.00)]; 14.0\u00a0mL ECV had 100% sensitivity and 100% specificity [AUC=1.00 (1.00-1.00)]; 1.27\u00a0mg\/mL I had 90.9% sensitivity and 100% specificity [AUC=0.99 (0.98-1.00)]; and 20.3% I% had 100% sensitivity and 100% specificity (AUC=1.00). Inter-reader agreement was near-perfect (ICCs 0.86 to 0.96).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>PCCT spectral parameters demonstrated excellent diagnostic performance in differentiating locally recurrent PDAC from postsurgical fibrosis on pancreatic parenchymal phase imaging.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rct.0000000000001935","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:00:10Z","timestamp":1791842410000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Pilot Study of Photon Counting CT Spectral Analysis Following Pancreatic Adenocarcinoma Resection to Differentiate Local Recurrence From Postsurgical Fibrosis"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4637-8370","authenticated-orcid":false,"given":"Samantha","family":"Platt","sequence":"first","affiliation":[{"name":"From the Department of Radiology, NYU Langone Health, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-7302","authenticated-orcid":false,"given":"Bhavik","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0647-5766","authenticated-orcid":false,"given":"Barun","family":"Bagga","sequence":"additional","affiliation":[{"name":"Department of Radiology, NYU Langone Health, Mineola, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3553-1306","authenticated-orcid":false,"given":"Thomas","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Siemens Healthineers, Malvern, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bari","family":"Dane","sequence":"additional","affiliation":[{"name":"From the Department of Radiology, NYU Langone Health, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"R1-20261012","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide burden of, risk factors for, and trends in pancreatic cancer","volume":"3","author":"Huang","year":"2021","journal-title":"Gastroenterology"},{"key":"R2-20261012","first-page":"7","article-title":"Cancer statistics, 2022","volume":"1","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R3-20261012","doi-asserted-by":"crossref","first-page":"10732748231173212","DOI":"10.1177\/10732748231173212","article-title":"Current treatment of potentially resectable pancreatic ductal adenocarcinoma: a medical oncologist\u2019s perspective","volume":"30","author":"de Jesus","year":"2023","journal-title":"Cancer Control"},{"key":"R4-20261012","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"9","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"R5-20261012","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11605-010-1378-5","article-title":"Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis","volume":"1","author":"Katz","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"R6-20261012","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"5","author":"Springfeld","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R7-20261012","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.acra.2021.10.025","article-title":"Pancreatic adenocarcinoma: diagnostic errors, contributing factors and solutions","volume":"7","author":"Budigi","year":"2022","journal-title":"Acad Radiol"},{"key":"R8-20261012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jscr\/2010.4.1","article-title":"Postsurgical pancreatitis masquerading as recurrent neuroendocrine cancer","volume":"4","author":"Adair","year":"2010","journal-title":"J Surg Case Rep"},{"key":"R9-20261012","first-page":"318","article-title":"Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the Society of Abdominal Radiology disease focus panel on PDAC","volume":"1","author":"Chu","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"R10-20261012","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3348\/kjr.2013.14.3.446","article-title":"Modified retroperitoneal access for percutaneous intervention after pancreaticoduodenectomy","volume":"3","author":"Pua","year":"2013","journal-title":"Korean J Radiol"},{"key":"R11-20261012","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00261-017-1374-2","article-title":"The Role of 18F-FDG PET\/CT and PET\/MRI in Pancreatic Ductal Adenocarcinoma","volume":"2","author":"Yeh","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"R12-20261012","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1007\/s00261-022-03605-2","article-title":"Crohn\u2019s disease active inflammation assessment with iodine density from dual-energy CT enterography: comparison with endoscopy and conventional interpretation","volume":"10","author":"Dane","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"R13-20261012","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00261-023-03923-z","article-title":"Crohn\u2019s disease phenotype analysis with iodine density from dual-energy CT enterography","volume":"7","author":"Dane","year":"2023","journal-title":"Abdominal Radiology"},{"key":"R14-20261012","first-page":"271","article-title":"Crohn\u2019s disease inflammation severity assessment with iodine density from photon counting CT enterography: comparison with endoscopic histopathology","volume":"1","author":"Dane","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"R15-20261012","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1148\/radiol.2021204405","article-title":"Crohn disease active inflammation assessment with iodine density from dual-energy CT enterography: comparison with histopathologic analysis","volume":"1","author":"Dane","year":"2021","journal-title":"Radiology"},{"key":"R16-20261012","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/jrr\/rrad076","article-title":"Dual-energy computed tomography-based iodine concentration as a predictor of histopathological response to preoperative chemoradiotherapy for pancreatic cancer","volume":"6","author":"Ohira","year":"2023","journal-title":"J Radiat Res"},{"key":"R17-20261012","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1148\/radiol.2015151560","article-title":"Correlation between dual-energy and perfusion CT in patients with hepatocellular carcinoma","volume":"1","author":"Gordic","year":"2016","journal-title":"Radiology"},{"key":"R18-20261012","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1007\/s00330-016-4597-7","article-title":"Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer","volume":"6","author":"Hellbach","year":"2017","journal-title":"Eur Radiol"},{"key":"R19-20261012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1148\/radiol.2015142631","article-title":"Dual- and multi-energy CT: principles, technical approaches, and clinical applications","volume":"3","author":"McCollough","year":"2015","journal-title":"Radiology"},{"key":"R20-20261012","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11604-025-01856-9","article-title":"Novel silicon-based material decomposition images in diagnosis of pancreatic ductal adenocarcinoma: comparison with iodine-based and 50-keV virtual monoenergetic images","volume":"1","author":"Noda","year":"2026","journal-title":"Jpn J Radiol"},{"key":"R21-20261012","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/RCT.0000000000000878","article-title":"Correlation between dual-energy computed tomography single scan and computed tomography perfusion for pancreatic cancer patients: initial experience","volume":"4","author":"Bao","year":"2019","journal-title":"J Comput Assist Tomogr"},{"key":"R22-20261012","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/RLI.0000000000000176","article-title":"Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?","volume":"10","author":"Stiller","year":"2015","journal-title":"Invest Radiol"},{"key":"R23-20261012","doi-asserted-by":"crossref","first-page":"109944","DOI":"10.1016\/j.ejrad.2021.109944","article-title":"Iodine concentration and tissue attenuation in dual-energy contrast-enhanced CT as a potential quantitative parameter in early detection of local pancreatic carcinoma recurrence after surgical resection","volume":"143","author":"Mathy","year":"2021","journal-title":"Eur J Radiol"},{"key":"R24-20261012","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40644-025-00866-0","article-title":"Predictive value of extracellular volume fraction determined using enhanced computed tomography for pathological grading of clear cell renal cell carcinoma: a preliminary study","volume":"1","author":"Liu","year":"2025","journal-title":"Cancer Imaging"},{"key":"R25-20261012","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3390\/jcm14062066","article-title":"Clinical significance of extracellular volume of myocardium (ECV) assessed by computed tomography: a systematic review and meta-analysis","volume":"6","author":"Martuszewski","year":"2025","journal-title":"J Clin Med"},{"key":"R26-20261012","doi-asserted-by":"crossref","first-page":"13643","DOI":"10.1038\/s41598-025-97677-x","article-title":"Prognostic impact of extracellular volume fraction derived from equilibrium contrast-enhanced CT in HCC patients receiving immune checkpoint inhibitors","volume":"1","author":"Fu","year":"2025","journal-title":"Sci Rep"},{"key":"R27-20261012","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.pan.2021.02.020","article-title":"Prognostic significance of extracellular volume fraction with equilibrium contrast-enhanced computed tomography for pancreatic neuroendocrine neoplasms","volume":"4","author":"Iwaya","year":"2021","journal-title":"Pancreatology"},{"key":"R28-20261012","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1007\/s00261-024-04313-9","article-title":"Interpretable machine learning based on CT-derived extracellular volume fraction to predict pathological grading of hepatocellular carcinoma","volume":"10","author":"Li","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"R29-20261012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1148\/radiol.14141435","article-title":"Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling","volume":"1","author":"Bandula","year":"2015","journal-title":"Radiology"},{"key":"R30-20261012","doi-asserted-by":"crossref","first-page":"110522","DOI":"10.1016\/j.ejrad.2022.110522","article-title":"Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer","volume":"156","author":"Fukui","year":"2022","journal-title":"Eur J Radiol"},{"key":"R31-20261012","doi-asserted-by":"crossref","first-page":"112273","DOI":"10.1016\/j.ejrad.2025.112273","article-title":"Contrast-enhanced CT-derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patients","volume":"191","author":"Ming","year":"2025","journal-title":"Eur J Radiol"},{"key":"R32-20261012","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/MPA.0000000000001427","article-title":"Estimation of extracellular volume fraction with routine multiphasic pancreatic computed tomography to predict the survival of patients with stage IV pancreatic ductal adenocarcinoma","volume":"10","author":"Fukukura","year":"2019","journal-title":"Pancreas"},{"key":"R33-20261012","doi-asserted-by":"crossref","first-page":"110756","DOI":"10.1016\/j.ejrad.2023.110756","article-title":"Extracellular volume fraction determined by dual-layer spectral detector CT: possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma","volume":"162","author":"Fujita","year":"2023","journal-title":"Eur J Radiol"},{"key":"R34-20261012","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ijrobp.2022.09.084","article-title":"Predicting treatment response from extracellular volume fraction for chemoradiation therapy of pancreatic cancer","volume":"3","author":"Noid","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R35-20261012","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/RCT.0000000000001847","article-title":"Extended validity of hematocrit for dual-energy CT extracellular volume calculation in cirrhosis: a 7-day window enhances clinical utility","volume":"50","author":"Han","year":"2026","journal-title":"J Comput Assist Tomogr"},{"key":"R36-20261012","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/diagnostics13050941","article-title":"Can imaging using radiomics and fat fraction analysis detect early tissue changes on historical CT scans in the regions of the pancreas gland that subsequently develop adenocarcinoma?","volume":"13","author":"Korn","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R37-20261012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41747-025-00567-0","article-title":"Contrast-enhanced photon-counting detector CT for discriminating local recurrence from postoperative changes after resection of pancreatic ductal adenocarcinoma","volume":"1","author":"Alagic","year":"2025","journal-title":"Eur Radiol Exp"},{"key":"R38-20261012","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmp.2020.10.030","article-title":"Photon-counting CT review","volume":"79","author":"Flohr","year":"2020","journal-title":"Phys Med"},{"key":"R39-20261012","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1148\/radiol.212579","article-title":"First clinical photon-counting detector CT system: technical evaluation","volume":"1","author":"Rajendran","year":"2022","journal-title":"Radiology"},{"key":"R40-20261012","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/RCT.0000000000001797","article-title":"Renal lesion assessment at portal venous phase photon counting computed tomography: iodine concentration and attenuation analysis","volume":"1","author":"Platt","year":"2026","journal-title":"J Comput Assist Tomogr"},{"key":"R41-20261012","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.acra.2024.02.006","article-title":"Photon counting computed tomography in rectal cancer: associations between iodine concentration, histopathology, and treatment response: a pilot study","volume":"9","author":"Surov","year":"2024","journal-title":"Acad Radiol"},{"key":"R42-20261012","first-page":"103","article-title":"Optimal conspicuity of pancreatic ductal adenocarcinoma in virtual monochromatic imaging reconstructions on a photon-counting detector CT: comparison to conventional MDCT","volume":"1","author":"Decker","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"R43-20261012","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s00261-024-04298-5","article-title":"Inter-reader agreement of pancreatic adenocarcinoma resectability assessment with photon-counting versus energy-integrating detector CT","volume":"9","author":"Kim","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"R44-20261012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/RCT.0000000000001771","article-title":"A pilot study to assess pancreatic adenocarcinoma treatment response with iodine density from photon counting CT","volume":"50","author":"Shou","year":"2026","journal-title":"J Comput Assist Tomogr"},{"key":"R45-20261012","doi-asserted-by":"crossref","first-page":"100426","DOI":"10.1016\/j.ejro.2022.100426","article-title":"Imaging response assessment for oncology: an algorithmic approach","volume":"9","author":"Ruchalski","year":"2022","journal-title":"Eur J Radiol Open"},{"key":"R46-20261012","doi-asserted-by":"crossref","first-page":"668697","DOI":"10.3389\/fmed.2021.668697","article-title":"The Value of (18)F-FDG PET\/CT in diagnosing pancreatic lesions: comparison with CA19-9, enhanced CT, or enhanced MR","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R47-20261012","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13193-011-0042-1","article-title":"Serum CA 19-9 as a biomarker for pancreatic cancer: a comprehensive review","volume":"2","author":"Ballehaninna","year":"2011","journal-title":"Indian J Surg Oncol"},{"key":"R48-20261012","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41598-020-57930-x","article-title":"CA19-9 for detecting recurrence of pancreatic cancer","volume":"1","author":"Azizian","year":"2020","journal-title":"Sci Rep"},{"key":"R49-20261012","doi-asserted-by":"crossref","first-page":"e2533625","DOI":"10.2214\/AJR.25.33625","article-title":"Adult abdominal photon-counting CT protocols: a multi-institutional consensus of the Society of Abdominal Radiology Photon-Counting Detector CT Emerging Technology Commission","volume":"6","author":"Dane","year":"2025","journal-title":"AJR Am J Roentgenol"},{"key":"R50-20261012","doi-asserted-by":"crossref","first-page":"15330338251336032","DOI":"10.1177\/15330338251336032","article-title":"Extracellular volume derived from equilibrium CT for the prediction of survival outcomes in patients with pancreatic ductal adenocarcinoma","volume":"24","author":"Xiong","year":"2025","journal-title":"Technol Cancer Res Treat"},{"key":"R51-20261012","doi-asserted-by":"crossref","first-page":"100711","DOI":"10.1016\/j.ejro.2025.100711","article-title":"MRI-derived extracellular volume fraction as a prognostic biomarker for early recurrence after R0 resection of pancreatic ductal adenocarcinoma","volume":"15","author":"Liu","year":"2025","journal-title":"Eur J Radiol Open"},{"key":"R52-20261012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajpath.2018.09.009","article-title":"The paradoxical web of pancreatic cancer tumor microenvironment","volume":"1","author":"Lafaro","year":"2019","journal-title":"Am J Pathol"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RCT.0000000000001935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:00:18Z","timestamp":1791842418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RCT.0000000000001935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":52,"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001935","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"2026-07-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}